Replying to:
Reliable Cancer Therapies-MGHI parnership
RCT (Reliable Cancer Therapies) have agreed to help financing the Fluvabrex Phase I trial that will investigate the tolerance and preliminary activity of fluvastatine and celecoxib in refractory low grade glioma. Recruitment shall start Q1-Q2 (...)